The Sepsis Diagnostics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Sepsis Diagnostics Market is estimated to be USD 934.54 million in 2018 and predicted to rise to USD 1405.88 million by 2023 with a CAGR of 8.8%. The market is segmented by Pathogen (Bacterial and Fungal), Product (Instruments, Blood Culture Media, Assay Kits and Reagents), Technology (Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry), Method (Conventional and Automated) and Usability (Laboratory and POC). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to hamper the growth of market.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
North America is leading the market while Europe is at second place. Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market. Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Browse through the full report at https://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/ and checkout our recent reports in the Diagnostics at https://www.marketdataforecast.com/subcategory/diagnostics-5/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.